Abstract
Provided is a method of treating a pathology associated with neural damage, the method comprising administering non-antigen specific polyclonal activated T cells and/or genetically modified T cells into the brain in a manner which prevents meningoencephalitis in the subject, thereby treating the pathology associated with neural damage. Also provided are devices for intrabrain and intrathecal administration of T cells, which comprise the brain-specific or non-antigen specific polyclonal activated T cells and/or genetically modified T cells and a catheter for intrabrain administration in a manner which prevents meningoencephalitis in a subject.
| Original language | English |
|---|---|
| Patent number | IL226359 |
| IPC | A61K 35/ 12 A N |
| Priority date | 17/11/11 |
| State | Published - 31 Jan 2018 |